A medical products company that has been on our Watch List for years has suddenly been placed on non-accrual by its main BDC lender, triggering a two step downgrade to a 5 rating.
This post is for paying subscribers only
You might also like...
Jan
14
Carestream Health Inc.: Downgraded By S&P Following Sale Of Subsidiaries
4 min read
Jan
07
Saratoga Investment: Actual Vs Expected Credit Performance - Quarter Ended November 2025
7 min read
Nov
10
Homerenew Buyer/Renovo Home Partners: Files Chapter 7